BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7862923)

  • 1. Effect of switching carbamazepine to oxcarbazepine on the plasma levels of neuroleptics. A case report.
    Raitasuo V; Lehtovaara R; Huttunen MO
    Psychopharmacology (Berl); 1994 Sep; 116(1):115-6. PubMed ID: 7862923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxcarbazepine in a carbamazepine-intolerant patient with bipolar affective disorder: a case report.
    Kalra H; Dalal PK; Allet L; Janca A
    Psychiatr Danub; 2006 Jun; 18(1-2):90-1. PubMed ID: 16804505
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome without fever after addition of oxcarbazepine to long-term treatment with amisulpride.
    Angelopoulos P; Markopoulou M; Kyamidis K; Bobotas K
    Gen Hosp Psychiatry; 2008; 30(5):482-4. PubMed ID: 18774435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of erectile dysfunction following a switch from carbamazepine to oxcarbazepine: recent clinical experience.
    Sachdeo R; Sathyan RR
    Curr Med Res Opin; 2005 Jul; 21(7):1065-8. PubMed ID: 16004674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders.
    Grant SM; Faulds D
    Drugs; 1992 Jun; 43(6):873-88. PubMed ID: 1379159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels.
    Stahl SM
    J Clin Psychiatry; 2004 Jun; 65(6):738-9. PubMed ID: 15291647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-onset hypersensitivity reaction with leukopenia and thrombocytopenia induced by oxcarbazepine treatment in a patient with schizoaffective disorder.
    Yeh YW; Wang TY; Huang CC; Chen YC
    J Clin Psychiatry; 2008 Apr; 69(4):676-8. PubMed ID: 18507488
    [No Abstract]   [Full Text] [Related]  

  • 8. Carbamazepine-induced changes in plasma levels of neuroleptics.
    Tiihonen J; Vartiainen H; Hakola P
    Pharmacopsychiatry; 1995 Jan; 28(1):26-8. PubMed ID: 7746842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overnight transition from carbamazepine to oxcarbazepine in children and adolescents.
    Vaisleib II; Neft RA
    Pharmacotherapy; 2008 Oct; 28(10):1211-4. PubMed ID: 18823216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency and safety of oxcarbazepine in mood disorders: a naturalistic study exploring the interest of plasma dosages.
    Misdrahi D; Tournier M; Droulout T; Grolleau A; Titier K; Molimard M; Verdoux H
    Eur Psychiatry; 2008 Sep; 23(6):409-12. PubMed ID: 18755575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxcarbazepine and hepatic porphyria.
    Pierach CA
    Epilepsia; 2002 Apr; 43(4):455; discussion 455. PubMed ID: 11952779
    [No Abstract]   [Full Text] [Related]  

  • 12. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxcarbazepine-induced thrombocytopenia.
    Mahmud J; Mathews M; Verma S; Basil B
    Psychosomatics; 2006; 47(1):73-4. PubMed ID: 16384812
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical feasibility of immediate overnight switching from slow-release carbamazepine to oxcarbazepine in Korean patients with refractory partial epilepsy.
    Lee SA; Heo K; Kim WJ; Song HK; Kim SE; Kim SH; No SK; Lee BI
    Seizure; 2010 Jul; 19(6):356-8. PubMed ID: 20538492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxcarbazepine as an adjunct for schizophrenia.
    Leweke FM; Gerth CW; Koethe D; Faulhaber J; Klosterkotter J
    Am J Psychiatry; 2004 Jun; 161(6):1130-1. PubMed ID: 15169712
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of inhalant-induced psychotic disorder with carbamazepine versus haloperidol.
    Hernandez-Avila CA; Ortega-Soto HA; Jasso A; Hasfura-Buenaga CA; Kranzler HR
    Psychiatr Serv; 1998 Jun; 49(6):812-5. PubMed ID: 9634163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of oxcarbazepine and carbamazepine: a double-blind study.
    Reinikainen KJ; Keränen T; Halonen T; Komulainen H; Riekkinen PJ
    Epilepsy Res; 1987 Sep; 1(5):284-9. PubMed ID: 3504404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxcarbazepine for epilepsy--a useful new choice?
    Drug Ther Bull; 2002 Jun; 40(6):46-8. PubMed ID: 12143266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxcarbazepine in affective and schizoaffective disorders.
    Dietrich DE; Kropp S; Emrich HM
    Pharmacopsychiatry; 2001 Nov; 34(6):242-50. PubMed ID: 11778145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug interaction can lead to undetectable serum concentrations of quetiapine in the presence of carbamazepine.
    Nickl-Jockschat T; Paulzen M; Schneider F; Grözinger M
    Clin Neuropharmacol; 2009; 32(1):55. PubMed ID: 19471186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.